Download presentation
Presentation is loading. Please wait.
Published byBathsheba Howard Modified over 9 years ago
1
Live, attenuated intranasal H1N1 vaccine
2
Indications Healthy people 2-24 years old Those 25-49 and – Live with or care for infants younger than 6 months – Health care or emergency medical personnel As becomes more available, any healthy 2-49 year old
3
Contraindications Allergy to: – Previous influenza vaccine – Eggs, egg products, gentamicin, gelatin, arginine Fever or acute illness Age less than 2 or greater than 49 Pregnant females Immunocompromised or contact with History Guillain-Barre syndrome Long term medical condition
4
Contraindications All not absolute – Discuss with nurse or physician May “qualify” for injection
5
Vaccine Considerations For 2009, only one manufacturer – MedImmune Supplied in pre-filled unit-dose nasal syringes Storage: 35-46° F (2-8° C) Can be administered at same time as any other vaccine EXCEPT another intra-nasal vaccine
6
Dosing 0.2mL (0.1mL per nostril) Dosing same regardless of age Age 2-9: 2 doses 3-4 weeks apart Age 10-49: 1 dose sufficient
7
Procedure Obtain and verify vaccine – Colorless to pale yellow – Clear to slightly cloudy – Some small proteinaceous particles may be present Ensure VAR complete
8
Procedure Patient in upright position Remove rubber tip protector Insert tip just inside nare Rapidly depress plunger until dose-divider clip stops Remove from nose, remove dose-divider clip, and administer remainder in opposite nare
9
Considerations If patient sneezes, no need to repeat Immunocompromised should not give vaccine Possible reactions – Runny nose or congestion – Fever, chills, malaise, myalgia – Headache, sore throat, nausea, vomiting
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.